A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations | MicrobiomeTrials← Back to trialsNCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-03-05Est. Completion: 2029-05
Enrollment target: 448 participants Locations- Research Site, Orlando, Florida, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, St Louis, Missouri, United States
- Research Site, New York, New York, United States
- Research Site, New York, New York, United States
- Research Site, Durham, North Carolina, United States
- Research Site, Nashville, Tennessee, United States
- Research Site, Houston, Texas, United States
- Research Site #2, San Antonio, Texas, United States
- Research Site, San Antonio, Texas, United States
- Research Site, Fairfax, Virginia, United States
Other microbiome trials you might be interested in
Lung Cancer Screening
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements…
Jackson, United StatesEst. completion Jun 1, 2027
PTCLNK T-Cell Lymphoma
This is a randomized, open-label, multicenter Phase III study evaluating the efficacy and safety of TR115, an EZH2 inhib…
Beijin, ChinaEst. completion Jul 30, 2029
Recruiting
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South KoreaEst. completion Jun 2027